BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 17186290)

  • 21. [A clinicopathological evaluation of prognostic factors of urothelial tumors of the renal pelvis and ureter].
    Oikawa T; Nomura H; Kinsui H; Hamano S; Suzuki N; Tanaka M; Murakami S; Nokubi M; Suzuki Y
    Hinyokika Kiyo; 2001 Apr; 47(4):237-40. PubMed ID: 11411096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.
    Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Krejci KG; Lobo JR; Sengupta S; Chen L; Zincke H; Blute ML; Strome SE; Leibovich BC; Kwon ED
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17174-9. PubMed ID: 15569934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract.
    Wirth GJ; Haitel A; Moschini M; Soria F; Klatte T; Hassler MR; Bensalah K; Briganti A; Karam JA; Lotan Y; Margulis V; Raman JD; Remzi M; Rioux-Leclercq N; Robinson BD; RouprĂȘt M; Wood CG; Shariat SF
    World J Urol; 2017 Jun; 35(6):943-949. PubMed ID: 27730305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of TLR4 and B7-H1 on immune escape of urothelial bladder cancer and its clinical significance.
    Wang YH; Cao YW; Yang XC; Niu HT; Sun LJ; Wang XS; Liu J
    Asian Pac J Cancer Prev; 2014; 15(3):1321-6. PubMed ID: 24606459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recurrent urothelial cancer after resection of ureteral carcinoma].
    Kong C; Ci J; Liu T
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):465-7. PubMed ID: 10920948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.
    Thalmann GN; Markwalder R; Walter B; Studer UE
    J Urol; 2002 Oct; 168(4 Pt 1):1381-5. PubMed ID: 12352398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Significance of Squamous Histology on Clinical Outcomes and PD-L1 Expression in Bladder Cancer.
    Gordetsky JB; Montgomery KW; Giannico GA; Rais-Bahrami S; Thapa P; Boorjian S; Frank I; Cheville J
    Int J Surg Pathol; 2022 Feb; 30(1):6-14. PubMed ID: 34180731
    [No Abstract]   [Full Text] [Related]  

  • 28. Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy.
    Thompson RH; Dong H; Kwon ED
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):709s-715s. PubMed ID: 17255298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urothelial Carcinoma of the Renal Pelvis and Ureter: Does Location Make a Difference?
    Lwin AA; Hsu CH; Chipollini J
    Clin Genitourin Cancer; 2020 Feb; 18(1):45-49.e1. PubMed ID: 31786118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinicopathological and prognostic value of PD-L1 in urothelial carcinoma: a meta-analysis.
    Wen Y; Chen Y; Duan X; Zhu W; Cai C; Deng T; Zeng G
    Clin Exp Med; 2019 Nov; 19(4):407-416. PubMed ID: 31407099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
    Aboumohamed AA; Krane LS; Hemal AK
    J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression.
    Konishi J; Yamazaki K; Azuma M; Kinoshita I; Dosaka-Akita H; Nishimura M
    Clin Cancer Res; 2004 Aug; 10(15):5094-100. PubMed ID: 15297412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between PD-L1 expression of the tumour cells and lymphocytes infiltration in the invasive front of urothelial carcinoma.
    Chen X; Chen H; Lin R; Li Y; Guo Y; Chen Q; Zhang Y; Cai G; Hu M; Chen G
    J Clin Pathol; 2023 Dec; 77(1):61-67. PubMed ID: 36319076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma.
    Masson-Lecomte A; Colin P; Bozzini G; Nison L; de La Taille A; Comperat E; Zerbib M; Rozet F; Cathelineau X; Valeri A; Ruffion A; Guy L; Droupy S; Cussenot O; RouprĂȘt M
    World J Urol; 2014 Apr; 32(2):531-7. PubMed ID: 23907662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
    Akdogan B; Dogan HS; Eskicorapci SY; Sahin A; Erkan I; Ozen H
    J Urol; 2006 Jul; 176(1):48-52. PubMed ID: 16753365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of Ki-67 labeling index in urothelial tumors of the renal pelvis and ureter.
    Masuda M; Iki M; Takano Y; Asakura T; Noguchi S; Ikeda I; Kubota Y; Hosaka M
    J Urol; 1996 Jun; 155(6):1877-80; discussion 1880-1. PubMed ID: 8618278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
    Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transitional cell carcinoma of upper urinary tract: some prognostic indicators.
    Gawley WF; Harney J; Glacken P; Hehir M; Rogers A; McKelvie G
    Urology; 1989 Jun; 33(6):459-61. PubMed ID: 2728147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of EIF5A2 in upper urinary tract urothelial carcinoma is a new independent prognostic marker of survival.
    Fang Y; Cen JJ; Cao JZ; Huang Y; Feng ZH; Lu J; Wei JH; Chen ZH; Liang YP; Liao B; Luo JH; Chen W
    Future Oncol; 2019 Jun; 15(17):2009-2018. PubMed ID: 30931608
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases.
    Leroy X; Gonzalez S; Zini L; Aubert S
    Am J Surg Pathol; 2007 May; 31(5):770-3. PubMed ID: 17460462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.